IFNA1 and COVID-19: Previous studies have reported an enrichment in IFN pathways in patients with moderate COVID-19, while patients with severe disease displayed increased inflammatory phenotype combined with decreased IFN production and reduced activation of DCs and monocytes (19, 21, 27–29).